Invesco
ELV icon

Invesco’s Elevance Health ELV Stock Holding History

Invesco’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,400
Closed -$718K – 3905
2022
Q4 		$718K Hold
1,400
– – ﹤0.01% 3097
2022
Q3 		$636K Hold
1,400
– – ﹤0.01% 3126
2022
Q2 		$676K Buy
+1,400
New +$693K ﹤0.01% 3185
2020
Q1 		– Sell
-11,400
Closed -$3.44M – 3665
2019
Q4 		$3.44M Hold
11,400
– – ﹤0.01% 2379
2019
Q3 		$2.74M Buy
11,400
+600
+6% +$164K ﹤0.01% 2466
2019
Q2 		$3.05M Buy
10,800
+2,600
+32% +$710K ﹤0.01% 2468
2019
Q1 		$2.35M Sell
8,200
-300
-4% -$86.8K ﹤0.01% 2506
2018
Q4 		$2.23M Sell
8,500
-200
-2% -$55K ﹤0.01% 2463
2018
Q3 		$2.38M Buy
+8,700
New +$2.26M ﹤0.01% 2639

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco's ELV Position: Q1 2026 in Review

Invesco increased its Elevance Health (ELV) stake by 23% in Q1 2026, buying an estimated $300M and bringing the position to 4,817,410 shares worth $1.41B. The position accounts for 0.14% of the portfolio, ranked #121.

Invesco first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.72B in Q4 2019. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Invesco held 4,817,410 shares of Elevance Health worth $1.41B as of Q1 2026.
  • Invesco bought 913,532 Elevance Health shares in Q1 2026, an estimated $300M.
  • Elevance Health made up 0.14% of Invesco's portfolio in Q1 2026, its #121 holding.
  • Invesco first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
  • Invesco's Elevance Health position peaked at $1.72B in Q4 2019.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.